Carbamazepine-induced liver injury is less common, but the consequences of the side effects can be very serious leading to death or a need for liver transplantation. We report a case of a 60-year-old female transverse myelitis patient with fulminant hepatic failure and Stevens-Johnson syndrome induced by carbamazepine who successfully underwent deceased donor liver transplantation. The patient, a 60-year-old female, was admitted to our service due to acute liver insufficiency and a drowsy mental state attributable to carbamazepine. She had been treated with carbamazepine to control transverse myelitis. Fifty days after the use of carbamazepine, she developed jaundice, erythematous papules and bullae, and decreased consciousness. The diagnosis of Stevens-Johnson syndrome was considered. She underwent deceased donor liver transplantation. She was discharged with normal graft functions 5 months after transplantation. Thus, liver transplantation can be a feasible therapy for patients with carbamazepine-induced hepatic failure associated with Stevens-Johnson syndrome. (J Korean Surg Soc 2011;80: 157-160)
INTRODUCTION
Transverse myelitis (TM) is a focal inflammatory disorder of the spinal cord. Carbamazepine is widely used to relieve the neuropathic pain, but it is frequently associated with neurologic adverse events, Stevens-Johnson syndrome (SJS), and hepatic side effects. Carbamazepine-induced liver injury is less common, but the consequences of the side effects can be very serious, leading to death or a need for liver transplantation. We report a case of a 60-year-old female with fulminant hepatic failure (FHF) and SJS induced by carbamazepine who successfully underwent deceased donor liver transplantation (DDLT). This is the first report in which neurologic and graft function in a patient with TM, FHF, and SJS recovered completely after DDLT.
CASE REPORT
The patient, a 60-year-old female, was admitted to a neurologic department in another hospital for sensorimotor weakness of lower extremities. T2-weighted magnetic resonance imaging of the spine revealed diffuse and ill-defined high signal intensities at the T8-10 level compatible with the neurologic deficit (Fig. 1) . With the results of other laboratory tests, she was diagnosed as idiopathic TM and was treated with intravenous high-dose steroid.
After the pulse therapy, the motor power of the lower extremities had improved significantly but she complained of intermittent lancinating pain in the legs. The patient in another hospital to control her sensory symptom. Fifty days after starting carbamazepine, she developed jaundice, erythematous papules, bullae, and skin erosions (Fig. 2) .
The patient was transferred to our liver unit because of acute liver insufficiency and a slowing of mentation, which was attributable to the carbamazepine.
On the initial physical examination, she was somnolent, 
